China is the largest market of Large Volume Parenteral Infusion Solutions in the world. Which are the Large Volume Parenteral Infusion Solutions manufacturers in China? PharmArch shares the list based on our research.
Sichuan Kelun Pharmaceutical Co Ltd(Kelun Pharmaceutical)
- Headquarters location: Sichuan Province, China
- Market Share: nearly 40%
Kelun, including more than 100 subsidiary corporations in China and abroad, is a the largest Large Volume Parenteral Infusion Solutions Manufacturer in China with annual sales revenue over 40 billion RMB. Kelun Pharmaceutical focus on China local market, and also do export business well. The leading infusion solutions have been exported to more than 40 countries and regions around the world.
In August 2018, Kelun Pharmaceutical passed the GMP Compliance Inspection of PMDA (Japanese Pharmaceuticals and Medical Devices Agency) as the first and only Chinese-funded IV solution manufacturer with this achievement.
China Resources Double Crane Pharmaceutical Company Limited (CR Double-Crane Pharmaceutical)
- Headquarters location: Beijing, China
- Market Share: around 15%
China Resources Double Crane Pharmaceutical Company Limited is a pharmaceuticals company with 75 years of brilliant history.CR Double-Crane Pharmaceutical starts the production of large volume injection (LVI) since 1997, and now is doing very well. As one of the leading Large Volume Parenteral Infusion Solutions manufacturer, CR Double-crane have good reputation in China market. At present, Double-crane owns many production bases with advanced technologies and equipment from German, Japan, Italy and other countries for infusion production
Main Large Volume Parenteral Infusion Solutions of CR Double-Crane Pharmaceutical are as below:
Basic injection: plastic bottle infusion, glass bottle infusion, polypropyrene bag infusion.
Therapeutic injection: Levofloxacin Methylate Injection), Ambroxol Hydrochloride and Glucose Injection, Fructose Injection, Hydroxyethyl Starch（200/0.5）and Sodium Chloride Injection, etc.
Nephrology products: peritoneal dialysis solution and hemofiltration replacement solution.
Shijiazhuang No. 4 Pharmaceutical Co Ltd.
- Headquarters location: Hebei Province, China
- Market Share: around 15%
Shijiazhuang No. 4 Pharmaceutical Co., Ltd., is one of the leading manufacturers in Chinese pharmaceutical industry for Large Volume Parenteral Infusion Solutions. The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.
Cisen Pharmaceutical Co Ltd
- Headquarters location:Shandong Province, China
- Market Share: around 10%
Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. One main business of Cisen Pharmaceutical Co., Ltd. is the manufacturing and sales of medicine, especially Large Volume Parenteral Infusion Solutions. Cisen Pharmaceutical’s global markets includes Southeast Asia, Middle East, South America and Africa.
Hebei Tiancheng Pharmaceutical Co Ltd
- Headquarters location: Hebei Province, China
- Market Share: around 5%
Hebei Tiancheng Pharmaceutical Co., Ltd is established in 1970 with more than 40 years’ professional experience of pharmaceuticals. The annual output of infusion products can reach 350 million bottles.
Shandong QiDu Pharmaceutical Co Ltd
- Headquarters location:Shandong Province, China
- Market Share: around 5%
Qidu Pharma Co. Ltd. is a comprehensive and research-based drug production enterprise which produces IV solutions, Oral preparations, APIs, etc. Products include basic infusions, intravenous nutrition liquid, plasma substitutes, anti-infective agents, antitumor drugs, internal secretion regulators and so on.
Guizhou Tiandi Pharmaceutical Co Ltd
- Headquarters location:Guizhou Province, China
- Market Share: around 5%
Guizhou Tiandi Pharmaceutical Co., Ltd. is one main Large Volume Parenteral Infusion Solutions Manufacturer in west of China. The annual production capacity of large volume injection is 360 million bottles (bags). The products are mainly sold to 18 provinces (regions) including Guizhou, Yunnan, Guangxi and Guangdong, and exported to some countries in Central Asia.
Except for the above 7 Large Volume Parenteral Infusion Solutions Manufacturers. Below companies also do production, but with smaller market share.
- Anhui BBCA Pharmaceutical Co LTD
- Shanxi Nuocheng Pharmaceutical Co Ltd
- Shandong Hualu Pharmaceutical Co Ltd
- CHIMIN Health Management Co Ltd
Above listed companies for reference only. Contact PharmaArch if premium sourcing service needed(Pharmaceutical Products from China).
